16 October 2024
Norman Broadbent plc
("Norman Broadbent" or the "Company")
Q3 2024 TRADING UPDATE
Resilient performance in Q3 with September being the highest monthly NFI in 2024
Norman Broadbent (AIM: NBB), a leading Executive Search and Interim Management firm, announces a trading update for the third quarter ended 30 September 2024 ("Q3").
Highlights
· Revenue of £2.7m, down 16% on Q3 2023 (£3.2m) and up 35% on Q3 2022 (£2.0m)
· NFI of £2.3m, down 18% on Q3 2023 (£2.8m) and up 35% on Q3 2022 (£1.7m)
o Q3 was the strongest quarter of the year, NFI was marginally up on Q2, with September being the highest monthly NFI in 2024
· Highest monthly value in 2024 of new retainers secured in September 2024, 33% above the year-to-date monthly average
· NFI to end of Q3 of £6.8m, down 14% on 2023 (£7.9m) and up 36% on 2022 (£5.0m)
Kevin Davidson, CEO of Norman Broadbent, said:
"Although market conditions continue to be challenging, I am pleased to report that we have held firm in our quarter-to-quarter performance, with a modest improvement on Q2 making Q3 the strongest of the year so far.
The standout performance in September was particularly gratifying and a welcome positive moving into the final quarter of the year which is traditionally our strongest.
While activity across our market remains subdued, following the UK Budget and US Presidential election and hopefully easing geopolitical tensions, we remain optimistic of an improving backdrop in 2025."
Contacts:
| Norman Broadbent plc | +44 (0)20 7484 0000 |
| Kevin Davidson, CEO | |
| Mehr Malik, CFO | |
| | |
| Shore Capital (Nominated Adviser and Broker) | +44 (0)20 7408 4090 |
| Tom Griffiths / Tom Knibbs (Corporate Advisory) | |
| Henry Willcocks (Corporate Broking) | |
| | |
| Alma (Financial Communications Adviser) | +44 (0)20 3405 0205 |
| Rebecca Sanders-Hewett | |
| Kinvara Verdon | |
| David Ison | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
